BioNTech SE
F:22UA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioNTech SE
F:22UA
|
DE |
|
E
|
Entergy Corp
F:ETY
|
US |
|
F
|
Fair Isaac Corp
F:FRI
|
US |
|
E
|
Evertec Inc
SWB:2EV
|
PR |
|
C
|
Cal-Maine Foods Inc
SWB:CM2
|
US |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
US |
|
88 Energy Ltd
ASX:88EDA
|
AU |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
Whitbread PLC
LSE:WTB
|
UK |
|
K
|
Kadant Inc
F:KDA
|
US |
|
H
|
Holcim AG
XMUN:HLBN
|
CH |
|
Cellnex Telecom SA
MAD:CLNX
|
ES |
|
K
|
KLA Corp
DUS:KLA
|
US |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
|
Amplitude Energy Ltd
F:CDP0
|
AU |
|
A
|
Amgen Inc
BMV:AMGN
|
US |
Bankruptcy Probability
BioNTech SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioNTech SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
24.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioNTech SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioNTech SE has total debt of 246.1m EUR. This includes both short-term (0 EUR) and long-term (246.1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
